Anne Tuggle, MD
Family Medicine · Mauldin, SCNPI 1518923531
Payments from drug & device makers
Across 468 payments — averaging $4481.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$2M
- AstraZeneca$43K
- Chiesi USA, Inc.$31K
- Genentech, Inc.$21K
- Genentech USA, Inc.$2K
- GSK$1K
- plus $7K from 32 others
Across 6 payments — averaging $13,628 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$82K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 46 | $1,992,281 |
| AstraZeneca | 40 | $43,018 |
| Chiesi USA, Inc. | 10 | $31,078 |
| Genentech, Inc. | 8 | $21,000 |
| Genentech USA, Inc. | 6 | $1,781 |
| GSK | 41 | $1,229 |
| AbbVie(2 entities) | 72 | $1,118 |
| Johnson & Johnson | 35 | $1,106 |
| Novo Nordisk | 28 | $806 |
| Daiichi Sankyo Inc. | 18 | $622 |
| Pfizer | 31 | $621 |
| Bayer | 23 | $513 |
| Lilly USA, LLC | 20 | $324 |
| Amgen | 9 | $311 |
| Sanofi-aventis U.S. LLC | 11 | $169 |
| Biohaven Pharmaceuticals, Inc. | 2 | $146 |
| Boehringer Ingelheim | 9 | $134 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $129 |
| Medtronic(2 entities) | 2 | $124 |
| Eisai Inc. | 6 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $85 |
| Abbott | 4 | $81 |
| Merck | 5 | $77 |
| Sanofi | 1 | $70 |
| Sunovion Pharmaceuticals Inc. | 6 | $64 |
| Esperion Therapeutics, Inc. | 4 | $60 |
| Amarin Pharma, Inc. | 3 | $56 |
| Astellas Pharma US Inc | 3 | $46 |
| Edwards Lifesciences | 1 | $30 |
| Exact Sciences | 2 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $27 |
| Philips North America LLC | 1 | $23 |
| Adlon Therapeutics L.p. | 1 | $20 |
| Novartis | 1 | $17 |
| Gilead | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Corcept Therapeutics | 1 | $14 |
How this compares
$2,097,352 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Mauldin
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
- Edward NewtonCharleston$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.